391 related articles for article (PubMed ID: 17414645)
21. SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer.
Saad F; Lipton A
Cancer Treat Rev; 2010 Apr; 36(2):177-84. PubMed ID: 20015594
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy.
Pinski J; Dorff TB
Eur J Cancer; 2005 Apr; 41(6):932-40. PubMed ID: 15808959
[TBL] [Abstract][Full Text] [Related]
23. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
24. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.
Amato RJ; Hernandez-McClain J; Henary H
Am J Clin Oncol; 2008 Dec; 31(6):532-8. PubMed ID: 19060583
[TBL] [Abstract][Full Text] [Related]
25. [Physiopathology and new therapeutic strategies in the management of bone metastases of prostate cancer].
Lebret T; Méjean A; Houédé N
Prog Urol; 2011 May; 21(5):301-7. PubMed ID: 21514531
[TBL] [Abstract][Full Text] [Related]
26. Novel targets and approaches in advanced prostate cancer.
Hadaschik BA; Sowery RD; Gleave ME
Curr Opin Urol; 2007 May; 17(3):182-7. PubMed ID: 17414516
[TBL] [Abstract][Full Text] [Related]
27. The role of bisphosphonates in the management of bone metastases in prostate cancer.
Saad F; Chi K; Fleshner N
Can J Urol; 2004 Oct; 11(5):2376-82. PubMed ID: 15576002
[TBL] [Abstract][Full Text] [Related]
28. Metastatic bone disease: future directions.
Clohisy DR
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S95-9. PubMed ID: 14600597
[TBL] [Abstract][Full Text] [Related]
29. Gene-modified bone marrow cell therapy for prostate cancer.
Wang H; Thompson TC
Gene Ther; 2008 May; 15(10):787-96. PubMed ID: 18385769
[TBL] [Abstract][Full Text] [Related]
30. Advances in the use of bisphosphonates in the prostate cancer setting.
Coxon JP; Oades GM; Colston KW; Kirby RS
Prostate Cancer Prostatic Dis; 2004; 7(2):99-104. PubMed ID: 14993897
[TBL] [Abstract][Full Text] [Related]
31. Role of targeted therapy in the treatment of advanced prostate cancer.
Fizazi K; Sternberg CN; Fitzpatrick JM; Watson RW; Tabesh M
BJU Int; 2010 Mar; 105(6):748-67. PubMed ID: 20353536
[TBL] [Abstract][Full Text] [Related]
32. Targeting the receptor activator of nuclear factor-kappaB (RANK) ligand in prostate cancer bone metastases.
Saad F; Markus R; Goessl C
BJU Int; 2008 May; 101(9):1071-5. PubMed ID: 18070191
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases.
Schwartz GG
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):478-83. PubMed ID: 18349265
[TBL] [Abstract][Full Text] [Related]
34. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
Russell MR; Jamieson WL; Dolloff NG; Fatatis A
Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002
[TBL] [Abstract][Full Text] [Related]
35. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
Yonou H; Ochiai A; Ashimine S; Maeda H; Horiguchi Y; Yoshioka K; Ogawa Y; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(9):999-1009. PubMed ID: 17440967
[TBL] [Abstract][Full Text] [Related]
36. Bone and prostate cancer cell interactions in metastatic prostate cancer.
Vela I; Gregory L; Gardiner EM; Clements JA; Nicol DL
BJU Int; 2007 Apr; 99(4):735-42. PubMed ID: 17166237
[TBL] [Abstract][Full Text] [Related]
37. Preservation of bone health in prostate cancer.
Lattouf JB; Saad F
Curr Opin Support Palliat Care; 2007 Oct; 1(3):192-7. PubMed ID: 18685362
[TBL] [Abstract][Full Text] [Related]
38. Future treatment of bone metastases.
Lipton A
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
[TBL] [Abstract][Full Text] [Related]
39. Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment.
Chirgwin JM; Guise TA
J Cell Biochem; 2007 Dec; 102(6):1333-42. PubMed ID: 17907152
[TBL] [Abstract][Full Text] [Related]
40. [Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy].
Hayashi S; Hanamura T
Clin Calcium; 2011 Mar; 21(3):389-96. PubMed ID: 21358060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
